Pharmacy Health Information Technology Collaborative Presenter: Shelly Spiro RPh, FASCP Pharmacy HIT Collaborative, Executive Director.

Slides:



Advertisements
Similar presentations
 QOC related to recognition & management of pain  Determine whether facility has provided & resident has received care & services to address & manage.
Advertisements

Introduction Medication non adherence ( noncompliance) remains a major problem. You have to assess and treat adherence related problems that can adversely.
Opioid Update F ederation of S tate M edical B oards Model Policy on the Use of Opioid Analgesics in the Treatment of Chronic Pain July 2013 F ederation.
Transitional Care Post Discharge; Tracking and Documentation.
429 pharmaceutical care Plan Refa’a AlAjmi. Goal of therpay A goal of therapy is the desired response or endpoint that you and your patient want to achieve.
Disease State Management The Pharmacist’s Role
The Value of Medication Therapy Management Services
{ ADVERSE DRUG REACTIONS To ensure patient, family/caregiver and home health personnel are instructed to identify adverse reactions to medications and.
Innovative Pharmacy Services Jann B. Skelton, RPh, MBA Vice President of Operations MEDICA.
Medication Regimen Review Guidance Training CFR § (c)(1)(2) F428.
Drug Utilization Review (DUR)
2.11 Conduct Medication Management University Medical Center Health System Lubbock, TX Jason Mills, PharmD, RPh Assistant Director of Pharmacy.
Medication Therapy Management Linda Mach, PharmD Bartell Drugs Community Practice Resident February 26, 2010.
Clinical Pharmacy II Lobna Al Juffali,MSc Fall-2009.
Establishing Preventive Cardiology Programs Nathan Wong Nathan Wong.
Determination of Highest Risk Patients Adult Patients.
JCAHO UPDATE June The Bureau of Primary Health Care is continuing to encourage Community Health Centers to be JCAHO accredited. JCAHO’s new focus.
Why are we learning this? How scientific knowledge (pharmacology, therapeutics) and clinical skills (measuring blood pressure, glucoses, drug information)
Community Health Team Care Management Process PinnacleHealth Systems Don DeArmitt, M.D. Becky E. Zook RN, BSN, MS, CCP.
CustomCare Programs After the Hospital and TLC Tracy Lin, PharmD, CACP After the Hospital At Home TLC.
Basma Y. Kentab MSc.. 1. Define ambulatory care 2. Describe the value of ambulatory care practices 3. Explore pharmacy services in some ambulatory care.
Pharmacists’ Expanded Scope of Practice in Canada as of Oct 2014 Source: Canadian Pharmacists Association.
The Value of Medication Therapy Management Services.
 1. A care plan is developed for each of the patient's medical conditions being managed with pharmacotherapy.  2. A goal of therapy is the desired response.
BEHAVIOR DRUG MONITORING A GUIDE TO MONITORING FOR PSYCHOPHARMACOLOGICAL BEHAVIORAL DRUG DOCUMENTATION.
DVT Prevention and Anticoagulant Management
Achieving Glycemic Control in the Hospital Setting Part 4 of 4.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 2 Application of Pharmacology in Nursing Practice.
Care Management 101 Governor's Office of Health Care Reform October 28, 2010 Cathy Gorski, RN, BS, CCM.
Medication Therapy Management Programs in Community Pharmacy Community Pharmacy October 17, 2006 Kurt A. Proctor, Ph.D., RPh Chief Operating Officer Community.
Managing Exercise in Persons with Multiple Chronic Conditions Chapter 04.
Mary Gardner, RN, MA, CCM, CDE Program Manager, High Risk Diabetes and COPD XLHealth Member Management Using The Med-eXpert System and Med-eMonitor Patient.
Quality Education for a Healthier Scotland Pharmacy Pharmaceutical Care Planning Vocational Training Scheme: Level = Stage 2 Arlene Shaw Specialist Clinical.
Transitions of Care: Using Pharmacists as Part of Team Based Care Care Transformation Collaborative of R.I. TARA HIGGINS, PHARMD, CDOE, CVDOE CLINICAL.
1 Impact of Implementing Designed Nursing Intervention Protocol on Clinical Outcome of Patient with Peptic Ulcer By Amal Mohamed Ahmad Assistant Professor,
Introduction.
Quality Improvement and Care Transitions in a Medical Home Maryland Learning Collaborative May 21, 2014 Stephanie Garrity, M.S., Cecil County Health Officer.
Pharmacists’ Patient Care Process
PRESENTING AUTHOR HAS NO RELATIONSHIPS TO DISCLOSE
Transforming Care in Patient Centered Medical Home and Accountable Care Organization Hae Mi Choe, PharmD Director, Pharmacy Innovations & Partnerships.
MTM Medication Therapy Management. What is Medication Therapy Management? From 1996 to 2006, the number of prescription medications dispensed increased.
Medication Therapy Management Part D Programs Presentation Developed for the Academy of Managed Care Pharmacy Updated: February 2014.
1 A Collaborative Approach to Transition Management.
Pharmacy Health Information Technology Collaborative Date: April 28, 2016 Presenter:Shelly Spiro, RPh, FASCP Pharmacy HIT Collaborative Executive Director.
Documentation in Practice Dept. of Clinical Pharmacy.
Sarah Thompson, PharmD, CDOE Director of Clinical Services, Coastal Medical.
Tribal Update Lummi Tribal Health Center
Medication Therapy Management (MTM)
Documentation of pharmaceutical care
of Patients with Acute Myocardial Infarction (AMI)
CMS 5 Star Rating.
Comments to the FDA on Conditions of Safe Use To Expand Which Drug Products Can Be Considered Nonprescription Marissa Schlaifer, RPh Director of Pharmacy.
Objectives of behavioral health integration in the Family Care Center
Strategies to Modernize State Medicaid Programs, Utah’s Medicaid Transformation By Lisa V. Hulbert R.Ph. Transformation Program Manager Utah Medicaid.
Clinical Pharmacy II.
Introduction to Clinical Pharmacy
DECREASING HOSPITALIZATIONS IN DIALYSIS PATIENTS
Opioid Prescribing & Monitoring
Treating Alcohol Abuse
Health Home Program Services for Patient 1st Medicaid Recipients
Health Home Program Services
The Nursing Process and Pharmacology Jeanelle F. Jimenez RN, BSN, CCRN
Comments to the FDA on Conditions of Safe Use To Expand Which Drug Products Can Be Considered Nonprescription Marissa Schlaifer, RPh Director of Pharmacy.
Information for Network Providers
The first screen used is designed to document symptom pursuit and review the complications of anticoagulation therapy. In addition this screen is where.
Pharmacy practice experience I
GHS Outpatient Enoxaparin Program
Pharmaceutical care planning 2 Ola Ali Nassr
Nutrition Interventions to Improve Quality of Care
Presentation transcript:

Pharmacy Health Information Technology Collaborative Presenter: Shelly Spiro RPh, FASCP Pharmacy HIT Collaborative, Executive Director

HAS SUPPORT HAS REASON Relationships Pharmacist Use Case 1 HEALTH CONCERNS Risk of bleeds or clots Ability to access anticoagulation clinic for labs Patient identified hyper/hypoglycemia PATIENT GOALS Prevention of clots and/or bleeds Maintain targeted BP Maintain targeted blood glucose level OBSERVATIONS Observation of some petechiae Lab values stable No patient reported bleeding events Multiple incidences of low BP INTERVENTIONS PERFORMED: Med reconciliation Assess contributing factors Patient education on BP and blood glucose monitoring and recording at least daily INR testing OTC interactions Diet restrictions Exercise INTERVENTIONS PLANNED Monitor INR & A1C Follow-up visit Review patient recorded BP and blood glucose results, lab results Review of dietary restrictions Assess need for medication changes Lower hypertensive medication OBSERVATIONS History of pulmonary embolism Hypertension Diabetes REFERS TO HAS COMPONENT EVALUATES PROGRESS TO GOALS On target for goals Re-enforce education SUPPORTS REFERS TO EVALUATIONS/OUTCOMES HAS COMPONENT HAS REASON

HAS SUPPORT HAS REASON Relationships Pharmacist Use Case 2 HEALTH CONCERNS Risk deep vein thrombosis Risk of uncontrolled pain Side effects of uncontrolled pain Depression Dietary disturbances Cognitive disturbances PATIENT GOALS Pain Management pre op and post op Prevention of DVT Prevention of infection OBSERVATIONS No indication of controlled substance misuse Moderate controlled pain on baseline assessment No allergy/interaction findings No indication of infection Patient understands symptoms to be monitored INTERVENTIONS PERFORMED Targeted med review PDMP check Assess potential allergies/interactions Pain assessment Patient education and counseling on Pain management Side effects of uncontrolled pain Symptoms of DVT INTERVENTIONS PLANNED Post discharge med reconciliation Assessment of Pain Assessment of side effects of pain management education OBSERVATIONS Scheduled for hip replacement REFERS TO HAS COMPONENT EVALUATES PROGRESS TO GOAL Pre op goal met SUPPORTS REFERS TO EVALUATIONS/OUTCOMES HAS COMPONENT HAS REASON

HAS SUPPORT HAS REASON Relationships Pharmacist Use Case 3 HEALTH CONCERNS Polypharmacy (multiple physicians & medications) Risk for non compliance Risk for duplicative therapy Risk of medication related adverse events risk of cognitive impairment affecting medication use GOALS Medication Adherence Optimize drug therapy Minimization drug therapy problems Coordination with care providers OBSERVATIONS Conflicting treatment strategies & medications Drug therapy problems Memory problems Confusion regarding instructions for medication use INTERVENTIONS PERFORMED Assessment of adherence barriers Complex medication regimens Functional status Cognitive status Rationalization of medication regimen CMR Identification of medication related adverse events Identification of drug therapy problems INTERVENTIONS PLANNED Care Coordination with treating physicians and care providers Follow-up visit to assess adherence Synchronization OBSERVATIONS History of Behavior health issues History of Multiple chronic diseases REFERS TO HAS COMPONENT EVALUATES PROGRESS TO GOALS Initiated actions to meet the goal Completed CMR and identified changes in medication regimen Initiated care coordination SUPPORTS REFERS TO EVALUATIONS/OUTCOMES HAS COMPONENT HAS REASON

HAS SUPPORT HAS REASON Relationships Pharmacist Use Case 4 HEALTH CONCERNS Polypharmacy (multiple physicians & pain medications) Risk of overdose Constipation/avoidance of impaction Malnutrition Impact of pain on chronic conditions GOALS Effective Pain Management Resolution of constipation Resolution of malnourishment Identification of PCP for patient Resolution of opioid abuse condition Care coordination with treating physicians & care providers OBSERVATIONS Conflicting treatment strategies & medications Decreased cognitive function Opioid over use INTERVENTIONS PERFORMED Assessment of Pain Medications and adherence for chronic conditions Complex medication regimens Cognitive sta tus CMR Rationalization of medication regimen Medication/education for constipation INTERVENTIONS PLANNED Referral to PCP Referral to Nutritionist Care Coordination with treating physicians and care providers Follow-up visit Synchronization OBSERVATIONS History of uncontrolled pain History of 3 chronic diseases Deteriorating health status (Malnutrition, constipation decreased cognitive ability.) REFERS TO HAS COMPONENT EVALUATES PROGRESS TO GOALS Initiated actions to meet the goal Completed CMR and identified changes in medication regimen Initiated care coordination SUPPORTS REFERS TO EVALUATIONS/OUTCOMES HAS COMPONENT HAS REASON

Put the ballot on hold until funds for project expert can be secured Set aside development of a specific Document Template for Pharmacist Care Plan Within NCPDP Pharmacy Professional Services WG, develop "guidance document" for how to use the "standard" Care Plan document template for the Pharmacist Care Plan use cases Guidance document would only discuss how the various Pharmacy Care Plan requirements are placed into the existing Care Plan template

Implementers will use the guidance document to implement an eCare Plan using the HL7 eCare Plan template At a later date, the information from this guidance document would be most of the material needed to generate the new template through the Lantana tools

Contact: Shelly Spiro Executive Director, Pharmacy HIT Collaborative 10